Lumen Bioscience Bags $5.5M to Develop Needle-Free Vaccines

Lumen Bioscience, a clinical-stage biopharma company developing biologic drugs for highly prevalent diseases, has received $5.5M in new funding from the US Department of Defense to develop technologies for needle-free vaccines.